Elenium’s touchless biometric fever detection kiosk set for rollout after regulatory approval
Australian technology company, Elenium Automation (EA), has announced that its touchless fever detection kiosk with eye tracking and voice biometrics, HealthGate, can now be rolled out after it earned a government regulatory approval.
The HealthGate kiosk uses eye tracking to enable user interactions with the health declaration technology incorporated into it through a contactless virtual touchscreen. Users interact with the HealthGate and answer the questions that make up the declaration by looking at the area they would press on a touchscreen.
EA says the device enables highly accurate and fast screening, using a multi-spectrum sensor and face biometrics to target the appropriate area of the face for temperature measurement to determine if the user has a fever. The device can conduct the screening for fever in less than two seconds, and needs no other party to operate the device during the screening process.
In addition to the virtual touchscreen technology and fever detection, the device also recognizes users with voice biometrics.
Reiterating the quality of HealthGate over other medical screening devices, Elenium Automation CEO Aaron Hornlimann, said: “One of the critical differences between HealthGate and other devices is the sophistication of our sensors. Thermometers that are relied upon in the market simply measure a person’s skin temperature at their forehead, which only tells you the temperature of that single spot, not whether they have a fever.”
But HealthGate, he said, “…takes accurate readings of specific areas on a person’s face like the inner canthi or the tear duct, where the blood vessels are near the surface of their skin,” to check if the individual actually has fever.
According to Elenium, the government approval for its device is in compliance with Australia’s regulatory requirements set out in the Therapeutic Goods Act 1989 (the Act), the Therapeutic Goods (Medical Devices) Regulations 2002 (the Regulations) and the Therapeutic Goods Regulation 1990.
The device is also said to come on the heels of results of a study commissioned by EA which showed that 88 percent of Australians were in favor of such touchless technology devices which help in reducing the likelihood of picking up infections. It is also designed to spur up “behavioral change” in a pandemic context where people expect much less contacts, the EA press statement adds.